Melanoma
From the Journals
Does screening for skin cancer result in melanoma overdiagnosis?
When the COVID-19 pandemic first hit, cancer screening in the United States came to an abrupt halt.
Conference Coverage
Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma
Results of German IMMUNED trial turn heads in advanced melanoma field.
Conference Coverage
Telltale dermoscopic features of melanomas lacking pigment reviewed
Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma...
Perspectives
COVID-19 vaccines and cancer patients: 4 things to know
Clinical Insights
How should we evaluate the benefit of immunotherapy combinations?
From the Journals
Phase 1 study: Beta-blocker may improve melanoma treatment response
“It’s exciting that an extremely inexpensive drug like propranolol that could be used in every country around the world could have an impact on...
Conference Coverage
‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma
Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.
From the Journals
Cancer rates on the rise in adolescents and young adults
Conference Coverage
Daily sunscreen use will prevent more melanoma deaths than early detection
“Prevention is low cost, low risk, and effective.”
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
Conference Coverage
Neoadjuvant immunotherapy combo produces high response rate in melanoma